Mum has recently been diagnosed with lung cancer (NSCLC carcinoma). They have started her on chemo (Vinorelbine + Cisplatin). Handling it amazingly and will start her second cycle soon. Radiotherapy may also be added depending on PET scan results (should know this week).
We are concerned about whether the NSCLC carcinoma subtype (e.g. adenocarcinoma / squamous cell carcinoma) is important, as we were advised they didn't establish this from the biopsy results. From what I've read so far, it appears to be important to establish treatment options (e.g. chemo drugs / targeted therapy / immune therapy).
Can chemo drug choice / radiotherapy be dependent on subtype? Can option of targeted / immune therapy be dependent on subtype? Is it important to establish the subtype at this stage? Should we be asking to have this checked?
So much going through our minds at the moment.
Many thanks for any advise. I wish you all the best.